Kurt Zumwalt - Jun 17, 2022 Form 4 Insider Report for OMEROS CORP (OMER)

Role: Director
Signature: /s/ Peter B. Cancelmo, Attorney-in-Fact
Stock symbol: OMER
Transactions as of: Jun 17, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/22/2022, 05:29 PM
Previous filing: May 27, 2022
Next filing: Jul 6, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OMER	Stock Option (Right to Buy)	Award	$0	+7.5K		$0.00	7.5K	Jun 17, 2022	Common Stock	7.5K	$2.00	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 17, 2022.
F2	This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date.

Content

Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 17, 2022.

This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date.